• Inflammatory Bowel Disease (IBD, ์—ผ์ฆ์„ฑ ์žฅ์งˆํ™˜)
  • ์†Œ์žฅ์„ฑ๊ณผ ๋Œ€์žฅ์„ฑ ๊ตฌ๋ถ„, ์†Œ์žฅ์„ฑ์ด ์ผ๋ฐ˜์ 
  • ๊ทธ๋ƒฅ ์žฅ์—ผ์ด์ง€๋งŒ ์ž„์ƒ์ ์œผ๋กœ ์ค‘์š”ํ•จ

Etiology

  • Idiopathic intestinal inflammation
  • Inappropriate immune response (๋ถ€์ ์ ˆํ•œ ๋ฉด์—ญ ๋ฐ˜์‘) : ์‹์ด์— ๋Œ€ํ•œ ๋ฉด์—ญ ๋ฐ˜์‘์ด ๊ณ„์†๋˜์–ด ์—ผ์ฆ ๋ฐœ์ƒ, ์„ธ๊ท  ๊ณผ์ฆ์‹์— ์˜ํ•œ ๋ฉด์—ญ ๋ฐ˜์‘์ด ์ง€์†๋˜์–ด ์žฅ์—ผ ๋ฐœ์ƒ ๋“ฑ ๋ณตํ•ฉ์ ์ธ ์›์ธ์„ ํฌํ•จ

Clinical Features

  • (1) Lymphocytic-Plamacytic Enteritis (LPE) : ๋น„ํŠน์ด์ ์ธ ์—ผ์ฆ ์งˆํ™˜
    • ๋งŒ์„ฑ์ ์ธ ์†Œ์žฅ์„ฑ ์„ค์‚ฌ
    • ์ฒด์ค‘์ด ๊ฐ์†Œํ•˜๊ณ  ๊ตฌํ† ํ•จ
    • IBD์— ์˜ํ•ด PLE๊ฐ€ ์ƒ๊ธธ ์ˆ˜ ์žˆ์Œ (์ง„๋‹จ๋ช…์ด ์•„๋‹Œ ํ•˜๋‚˜์˜ ์ฆ์ƒ, ๊ธฐ์ € ์งˆํ™˜์„ ์ฐพ์•„์•ผ)
    • R/O : alimentary lymphoma
      • lymphocyte๋Š” round cell
      • ๋ณดํ†ต lymphoblastic lymphoma๋Š” B cell ์œ ๋ž˜์ธ ๊ฒฝ์šฐ๊ฐ€ ๋งŽ์•„ ์„ธํฌ๊ฐ€ ํผ.
      • ๊ณ ์–‘์ด์—์„œ ์ž˜ ๋ฐœ์ƒํ•˜๋Š” small cell lymphoma๋Š” small T cell ์œ ๋ž˜๋กœ, ๋ถ„ํ™”๊ฐ€ ์ž˜ ๋˜์–ด ์žˆ์–ด์„œ ๊ฑฐ์˜ ์ •์ƒ์— ๊ฐ€๊นŒ์šด lymphocyte, ๊ตฌ๋ถ„์ด ์–ด๋ ค์›€. ๋ฉด์—ญ๊ฒ€์‚ฌ๋กœ ์ข…์–‘ํ‘œ์ง€์ž๋ฅผ ํ™•์ธํ•ด์•ผ ์ง„๋‹จ ๊ฐ€๋Šฅ.
      • ์†Œ์„ธํฌ์„ฑ ๋ฆผํฌ๋งˆ์™€ ๊ฐ๋ณ„ ์–ด๋ ค์›€
  • (2) Eosinophilic Gastro Enterocolitis (EGE) : ์†Œ์žฅ์—๋„, ๋Œ€์žฅ์—๋„ ์ƒ๊ธธ ์ˆ˜ ์žˆ์Œ
    • LPE์— ๋น„ํ•ด ๋“œ๋ฌพ
    • ๋‹จ๋ฐฑ์งˆ์›์— ์˜ํ•œ ์•Œ๋Ÿฌ์ง€ ๋ฐ˜์‘์ผ ๋•Œ๊ฐ€ ๋งŽ์Œ (beef, milk)
    • ๋ฉด์—ญ์–ต์ œ์ œ๋ฅผ ์“ฐ๋ฉด ๋Œ€๋ถ€๋ถ„ ๋ฐ˜์‘์ด ์ข‹์ง€๋งŒ,
      • Feline hypereosinophilic syndrome (HES, ํ˜ธ์‚ฐ๊ตฌ๊ฐ€ ์˜จ๋ชธ์— ์นจ์œค๋˜๋Š” ์ฆํ›„๊ตฐ)์ด ์ƒ๊ธฐ๋ฉด ์˜ˆํ›„๊ฐ€ ์•ˆ ์ข‹์Œ
        • ์ผ์ข…์˜ ์ข…์–‘์„ฑ ๋ณ‘๋ณ€, ์›๋ž˜๋Š” ๊ณจ์ˆ˜ ๊ฒ€์‚ฌ๋ฅผ ํ•ด์„œ ์ „๊ตฌ์„ธํฌ ๋งŽ์ด ์ฆ์‹ํ•˜๊ณ  ํ˜ธ์‚ฐ๊ตฌ๊ฐ€ ์ •์ƒ๋ณด๋‹ค 5-10๋ฐฐ ๋†’์€ ๊ฒƒ์„ ํ™•์ธ
        • ์น˜๋ฃŒ์  ์ง„๋‹จ์ด ์œ ์šฉ โ†’ ์žฅ์—ผ์— ์ค€ํ•˜๋Š” ์Šคํ…Œ๋กœ์ด๋“œ&์‹์ด๊ด€๋ฆฌ๋ฅผ ํ•ด๋„ ๋ฐ˜์‘์ด ์—†๊ณ  ๊ณ„์† ๋‚˜๋น ์ง
        • ๊ฐœ์—์„œ๋Š” ์—†์œผ๋ฏ€๋กœ, ํ˜ธ์‚ฐ๊ตฌ ์นจ์œค์„ฑ ์žฅ์—ผ์ด์–ด๋„ ๊ด€๋ฆฌ๊ฐ€ ์ž˜๋จ (?)

Diagnosis (LPE)

  • ์ง„๋‹จ์  ๊ฐ€์น˜๊ฐ€ ๋–จ์–ด์ง. ํ™•์ง„ ์–ด๋ ค์›€.

  • Exclusion DDx + Histopathology : ์„ค์‚ฌ์˜ ๋‹ค๋ฅธ ์›์ธ์„ ๋‹ค ๋ฐฐ์ œํ•œ ์ƒํƒœ์—์„œ ์กฐ์ง ๊ฒ€์‚ฌ๋ฅผ ํ–ˆ๋Š”๋ฐ LPE ์†Œ๊ฒฌ์ด ๋‚˜์˜ค๋ฉด ์ง„๋‹จ ๊ฐ€๋Šฅ.

  • First, ์„ค์‚ฌ์˜ ์›์ธ์„ ๋ฐฐ์ œ

    • ์Œ์‹ ๋ฐ˜์‘์„ฑ(โ†’ elimination diet), ํ•ญ์ƒ์ œ ๋ฐ˜์‘, ๊ธฐ์ƒ์ถฉ(โ†’ ๊ตฌ์ถฉ), ์ข…์–‘ ๊ฐ๋ณ„
  • Second, Histopathology

    • Mucosal inflammatory infiltrates (์ ๋ง‰์˜ ์—ผ์ฆ์„ธํฌ ์นจ์œค; lymphocyte, plasmacytes)
    • Architectural changes (villus atropy, crypt changes)
    • Epithelial changes (์ ๋ง‰ ์ƒํ”ผ์„ธํฌ ๋ณ€์„ฑ)
  • ๊ณ ์–‘์ด๋Š” well-differenciated(๋ถ„ํ™”๊ฐ€ ์ž˜๋˜๋Š”) small cell lymphocytic lymphoma ์™€ ๊ฐ๋ณ„์ด ์–ด๋ ค์›€.

    • ๋ฉด์—ญํ™”ํ•™๊ฒ€์‚ฌ(์ข…์–‘์„ธํฌ์—์„œ๋งŒ ๋ฐœํ˜„๋˜๋Š” ๊ฒ€์‚ฌ)๋ฅผ ๋”ฐ๋กœ ํ•ด์•ผํ•จ.

Diagnosis (EGE)

  • ๊ฐœ์—์„œ๋Š” eosinophilia ๋‚˜ํƒ€๋‚˜๊ธฐ๋„, ์•ˆ ๋‚˜ํƒ€๋‚˜๊ธฐ๋„.
    • ํ˜ธํก๊ธฐ/ํ”ผ๋ถ€์˜ ํ˜ธ์‚ฐ๊ตฌ ์นจ์œค
    • German Sheperds ์—์„œ ํ˜ธ์‚ฐ๊ตฌ์„ฑ ์žฅ์—ผ โ†‘
  • ๊ณ ์–‘์ด์—์„œ ์—ผ์ฆ์„ฑ ์žฅ์งˆํ™˜์ธ๋ฐ ํ˜ธ์‚ฐ๊ตฌ์ฆ๊ฐ€์ฆ์ด ์žˆ๋‹ค๋ฉด EGE ๊ฐ€๋Šฅ์„ฑ ๋†’์Œ.
    • ํ˜ˆ์ค‘ eosiophil ๋†’์•„์ง€๋Š”๊ฒŒ ์ผ๋ฐ˜์ 
    • splenic, hepatic, lymph node, bone marrow ๋“ฑ ๊ด€๊ณ„์—†์–ด๋ณด์ด๋Š” ๋ถ€๋ถ„์— infiltrates..
    • ์น˜๋ฃŒ๋ฅผ ํ•ด๋ณด๊ณ , ๋ฐ˜์‘์ด ์—†์œผ๋ฉด HES๋กœ ์ง„๋‹จ

Treatment

Canine LPE<
Elimination diets
+ Antimicrobials
- ๋ณดํ†ต ๊ฒฝ๋ฏธํ•จ. ์žฅ์„ธํฌ ์†์ƒ์ด ์‹ฌํ•˜์ง€ ์•Š์€ ์ดˆ๊ธฐ์—๋Š” ์น˜๋ฃŒ ์ˆ˜์›”.
- EGE๋ฟ ์•„๋‹ˆ๋ผ LPE๋„ ์‹์ด์— ์˜ํ•ด ์ƒ๊ธธ ์ˆ˜ ์žˆ์Œ.
- ์ผ๋‹จ ์‹์ด+ํ•ญ์ƒ์ œ๊ฐ€ first.
Corticosteroid therapy
(PDS 2.2mg/kg/day PO)
- Moderate โ†’ ์ถ”๊ฐ€์ ์œผ๋กœ ๋ฉด์—ญ์–ต์ œ์ œ ์‚ฌ์šฉ
- Steroid : 1mg/kg ์ดํ•˜๋กœ ์“ฐ๋ฉด ํ•ญ์—ผ์ฆ ๋ฐ˜์‘, ๋งŽ์ด ์“ฐ๋ฉด ๋ฉด์—ญ์–ต์ œ ๋ฐ˜์‘
Immunosuppressives- Steroid ์˜ค๋ž˜ ์จ์„œ ๋ถ€์ž‘์šฉ ์šฐ๋ ค or ์ฟ ์‹ฑ ๋“ฑ ์Šคํ…Œ๋กœ์ด๋“œ ๋ถˆ๊ฐ€๋Šฅํ•œ ํ™˜์ž์—์„œ๋Š”..
- budesonide (PDS sparing drugs)
: ์ „์‹  ์—ผ์ฆ ์ค„์ด๋Š” PDS์™€ ๋‹ฌ๋ฆฌ budesonide๋Š” ์žฅ์—๋งŒ ๊ตญ์†Œ์ ์œผ๋กœ ์ž‘์šฉํ•˜๋Š” ์Šคํ…Œ๋กœ์ด๋“œ. ๋ถ€์ž‘์šฉ์ด ํ›จ์”ฌ ์ž‘์Œ.
- Azathioprine : ์˜ค๋ž˜ ์“ฐ๋ฉด ๊ณจ์ˆ˜์–ต์••, ๊ฐ„๋…์„ฑ / ๊ณ ์–‘์ด๋Š” ๋Œ€์‚ฌ๊ฐ€ ๋นจ๋ผ ๋ถˆ๊ฐ€.
- Chlorambucil : ํ•ญ์•”์ œ(=๊ฐ•๋ ฅํ•œ ๋ฉด์—ญ์–ต์ œ์ œ). ๊ณ ์–‘์ด์—์„œ Azathioprine ๋Œ€์‹  ์“ฐ๊ธฐ ์ข‹์Œ.
- Cyclosporine
Cobalamin therapy- Cobalamin(VB12) : ์žฅ์„ธํฌ์˜ ์žฌ์ƒ๊ณผ ํšŒ๋ณต์„ ๋„์›€.
*์ ์ ˆํ•œ ์น˜๋ฃŒ ์‹คํŒจ?- ์ž˜๋ชป๋œ ์น˜๋ฃŒ ๋ฐฉํ–ฅ
- ๋ณดํ˜ธ์ž๊ฐ€ ์•ฝ์„ ์ž˜ ์•ˆ ๋จน์ผ ์ˆ˜ ์žˆ์Œ์„ ์˜์‹ฌ (โ†’ ๋ฐ˜์‘ ์•ˆ ๋‚˜ํƒ€๋‚œ๋‹ค๊ณ  ๋ฐ”๋กœ ์šฉ๋Ÿ‰ ์˜ฌ๋ฆฌ๊ธฐ๋ณด๋‹จ..)
- Misdiagnosis : lymphoma๋ฅผ ์˜ค์ง„ํ–ˆ์„ ์ˆ˜ ์žˆ์Œ
Feline LPE<
Elimination diet + Metronidazole๊ธฐ๋ณธ์ ์œผ๋กœ ์ด๋ ‡๊ฒŒ ์‹œ์ž‘
Steroid - ์ดˆ๊ธฐ๋ถ€ํ„ฐ ๊ณ ์šฉ๋Ÿ‰- Steroid๊ฐ€ potency๊ฐ€ ์ข‹์•„์„œ, ์ผ๋‹จ ์ดˆ๊ธฐ์— ์žก์Œ.
- ๋‹น๋‡จ ๋“ฑ ์“ธ ์ˆ˜ ์—†์œผ๋ฉด budesonide ๊ฐ€๋Šฅ
Chlorambucil (ํ•ญ์•”์ œ)- Severe LPE๋‚˜ ๊ณ ์–‘์ด์˜ small cell lymphoma ๋‘˜ ๋‹ค ์ ์šฉ ๊ฐ€๋Šฅ
- ์ง„๋‹จ์ด ์–ด๋ ค์šธ ๋•Œ ๋งŽ์ด ์”€
Cobalamin therapy,
Nutritional supplementation
- parenterally : ์ด๋Ÿฐ ๊ฒฝ์šฐ๊ฐ€ ๋งŽ์ง€๋Š” ์•Š์Œ
Canine EGE<
Strict elimination diet- EGE๋Š” ํ™•์‹คํ•˜๊ฒŒ ์ œํ•œ ์‹์ด. ์ตœ์†Œ 8์ฃผ ๋™์•ˆ ๋ฌผ๊ณผ ์ œํ•œ ์‚ฌ๋ฃŒ๋งŒ ๊ธ‰์—ฌ.
- ๊ฐ„์‹ ์ฃผ์ง€ ๋ง๋ผ๊ณ  ๊ผญ ๊ฐ•์กฐํ•ด์•ผ ํ•จ!! (๋ฌผ๊ณผ ์‚ฌ๋ฃŒ ์™ธ์— ๋“ค์–ด๊ฐ€๋ฉด X)
- ์ œํ•œ์‚ฌ๋ฃŒ ์™ธ์˜ ๊ฒƒ์„ ๋จน์œผ๋ฉด ๋‹ค์‹œ 0์ผ๋ถ€ํ„ฐ ์‹œ์ž‘
- ์‹ฌ์žฅ์‚ฌ์ƒ์ถฉ์•ฝ(ํ•˜ํŠธ๊ฐ€๋“œ)๋„ ๊ธˆ์ง€!! (๋ฐ”๋ฅด๋Š” ์•ฝ์œผ๋กœ ๋ณ€๊ฒฝ)
Corticosteroid therapy
์žฌ๋ฐœํ•œ๋‹ค๋ฉด,- ์‚ฌ๋ฃŒ๋ฅผ 2์ฃผ ๊ฐ„๊ฒฉ์œผ๋กœ ๋ฐ”๊ฟ”์„œ back and forth๋กœ ๊ธ‰์—ฌ
Feline EGEHES๊ฐ€ ์žˆ๋Š”์ง€ ์—†๋Š”์ง€๊ฐ€ ์ค‘์š”
Steroid therapy์Šคํ…Œ๋กœ์ด๋“œ ์น˜๋ฃŒ๋Š” ๋˜‘๊ฐ™์ง€๋งŒ, HES๊ฐ€ ์žˆ์œผ๋ฉด ๋ฐ˜์‘์ด ์—†๋‹ค.
Steroid Tapering- IBD๋Š” ๋งŒ์„ฑ์ , ๋ชธ์ด ์ธ์ง€ํ•˜์ง€ ๋ชปํ•˜๊ฒŒ ์„œ์„œํžˆ.
- Steroid + Aza, cyclo ๋“ฑ๊ณผ ๋ณ‘์šฉํ•  ๋•Œ๊ฐ€ ๋งŽ์€๋ฐ,
- ์ตœ์†Œ 2-4์ฃผ๋Š” ์•ฝ์„ ์ค„์ด์ง€ ์•Š์•„์•ผ.
- ํ•œ ๋ฒˆ์— ํ•œ ๊ฐœ์”ฉ๋งŒ ๊ฐ๋Ÿ‰ (๋ฐ˜์‘์„ฑ ํ™•์ธ)
- 2-3์ฃผ์— 1๋ฒˆ ๊ฐ๋Ÿ‰, 1๊ฐœ ์ด์ƒ ๊ฐ๋Ÿ‰ํ•˜์ง€ ์•Š์Œ
- ์‚ฌ๋ฃŒ ๊ด€๋ฆฌ, ํ•ญ์ƒ์ œ ๊ด€๋ฆฌ๋Š” ๊ณ„์† ์ง€์† (๊ฐ๋Ÿ‰ํ•˜๋ฉด์„œ ์žฌ๋ฐœ ์ง„์งœ ๋งŽ์Œ)

Prognosis

  • ์ž˜ ๊ด€๋ฆฌํ•˜๋ฉด ์˜ˆํ›„๋Š” ์ข‹์€ ํŽธ
  • Poor sings
    • Severe ์งˆํ™˜์ด ๋งŽ์ด ์ง„ํ–‰๋˜์–ด severe hypoalbuminemia
    • Poor body condition score
  • ํ‰์ƒ ์‹์ด ๊ด€๋ฆฌ ํ•ด์ค˜์•ผ ํ•จ
  • ์ž˜ ์ฃฝ์ง€๋Š” ์•Š์ง€๋งŒ, ์•ฝ๋ฌผ์€ ๊ณ„์† ์‚ฌ์šฉ. ์ฆ์ƒ์€ ์žกํžˆ์ง€๋งŒ ๊ณ„์† ๊ด€๋ฆฌํ•ด์•ผ ํ•œ๋‹ค๋Š” ๊ฒƒ ๊ฐ•์กฐ
    • Iatrogenic Cushing syndrome (์˜์ธ์„ฑ ์ฟ ์‹ฑ) ์กฐ์‹ฌ